Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 54 publications
Predictors of Target Lesion Failure in Patients With In-Stent Restenosis: Insights From the AGENT IDE Trial.
Journal: Circulation. Cardiovascular interventions
Published: August 06, 2026
Paclitaxel-Coated Balloon Versus Uncoated Balloon for Coronary In-Stent Restenosis: Two-Year Follow-Up of the AGENT-IDE Randomized Clinical Trial.
Journal: Circulation
Published: July 06, 2026
Impact of Restenosis Pattern on the Safety and Efficacy of Paclitaxel-Coated Balloon Versus Uncoated Balloon for Coronary In-Stent Restenosis.
Journal: Circulation. Cardiovascular interventions
Published: January 26, 2026
Paclitaxel-Coated Balloon for Treating In-Stent Restenosis in Racial and Ethnic Minority Patients: A Subanalysis From the AGENT IDE Trial.
Journal: Journal of the American Heart Association
Published: January 19, 2026
Efficacy and Safety of Paclitaxel-Coated Balloon Angioplasty in Patients With In-Stent Restenosis With vs Without Diabetes.
Journal: Journal of the Society for Cardiovascular Angiography & Interventions
Published: December 02, 2025
Rare variable M. tuberculosis antigens induce predominant Th17 responses in human infection.
Journal: JCI insight
Published: November 06, 2025
Paclitaxel-Coated Balloon for the Treatment of Small Vessel In-Stent Restenosis: A Subgroup Analysis of the AGENT IDE Randomized Trial.
Journal: JACC. Cardiovascular interventions
Published: July 28, 2025
Peptide exchange-competent class I MHC molecules produced in eukaryotic cells for rapid production of MHC multimers.
Journal: Journal of immunology (Baltimore, Md. : 1950)
Published: June 05, 2025
Intravascular Imaging vs Angiography Guidance for PCI of Severely Calcified Lesions: The ECLIPSE Trial.
Journal: JACC. Cardiovascular interventions
Published: April 25, 2025
Paclitaxel-Coated Balloon for the Treatment of Multilayer In-Stent Restenosis: AGENT IDE Subgroup Analysis.
Journal: Journal of the American College of Cardiology
Published: March 19, 2025
Rare Variable M. tuberculosis Antigens induce predominant Th17 responses in human infection.
Journal: bioRxiv : the preprint server for biology
Published: March 18, 2024
Last Updated: 09/26/2026